132 related articles for article (PubMed ID: 27061056)
1. Activated factor VII-antithrombin complex predicts mortality in patients with stable coronary artery disease: a cohort study.
Martinelli N; Girelli D; Baroni M; Guarini P; Sandri M; Lunghi B; Tosi F; Branchini A; Sartori F; Woodhams B; Bernardi F; Olivieri O
J Thromb Haemost; 2016 Apr; 14(4):655-66. PubMed ID: 27061056
[TBL] [Abstract][Full Text] [Related]
2. Apolipoprotein C-III Strongly Correlates with Activated Factor VII-Anti-Thrombin Complex: An Additional Link between Plasma Lipids and Coagulation.
Martinelli N; Baroni M; Castagna A; Lunghi B; Stefanoni F; Tosi F; Croce J; Udali S; Woodhams B; Girelli D; Bernardi F; Olivieri O
Thromb Haemost; 2019 Feb; 119(2):192-202. PubMed ID: 30602199
[TBL] [Abstract][Full Text] [Related]
3. Activated factor XI is associated with increased factor VIIa - Antithrombin complexes in stable coronary artery disease: Impact on cardiovascular outcomes.
Paszek E; Pociask E; Ząbczyk M; Butenas S; Undas A
Eur J Clin Invest; 2022 Dec; 52(12):e13857. PubMed ID: 35996895
[TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein C-III predicts cardiovascular mortality in severe coronary artery disease and is associated with an enhanced plasma thrombin generation.
Olivieri O; Martinelli N; Girelli D; Pizzolo F; Friso S; Beltrame F; Lotto V; Annarumma L; Corrocher R
J Thromb Haemost; 2010 Mar; 8(3):463-71. PubMed ID: 20002542
[TBL] [Abstract][Full Text] [Related]
5. Aptamer-modified FXa generation assays to investigate hypercoagulability in plasma from patients with ischemic heart disease.
Baroni M; Martinelli N; Lunghi B; Marchetti G; Castagna A; Stefanoni F; Pinotti M; Woodhams B; Olivieri O; Bernardi F
Thromb Res; 2020 May; 189():140-146. PubMed ID: 32224381
[TBL] [Abstract][Full Text] [Related]
6. Increased plasma thrombin potential is associated with stable coronary artery disease: An angiographically-controlled study.
Tosi F; Micaglio R; Sandri M; Castagna A; Minguzzi D; Stefanoni F; Chiariello C; Franzese I; Luciani GB; Faggian G; Girelli D; Olivieri O; Martinelli N
Thromb Res; 2017 Jul; 155():16-22. PubMed ID: 28477533
[TBL] [Abstract][Full Text] [Related]
7. Associations of activated coagulation factor VII and factor VIIa-antithrombin levels with genome-wide polymorphisms and cardiovascular disease risk.
Olson NC; Raffield LM; Lange LA; Lange EM; Longstreth WT; Chauhan G; Debette S; Seshadri S; Reiner AP; Tracy RP
J Thromb Haemost; 2018 Jan; 16(1):19-30. PubMed ID: 29112333
[TBL] [Abstract][Full Text] [Related]
8. Basophil Blood Cell Count Is Associated With Enhanced Factor II Plasma Coagulant Activity and Increased Risk of Mortality in Patients With Stable Coronary Artery Disease: Not Only Neutrophils as Prognostic Marker in Ischemic Heart Disease.
Pizzolo F; Castagna A; Olivieri O; Girelli D; Friso S; Stefanoni F; Udali S; Munerotto V; Baroni M; Cetera V; Luciani GB; Faggian G; Bernardi F; Martinelli N
J Am Heart Assoc; 2021 Feb; 10(5):e018243. PubMed ID: 33624506
[TBL] [Abstract][Full Text] [Related]
9. Factor II activity is similarly increased in patients with elevated apolipoprotein CIII and in carriers of the factor II 20210A allele.
Olivieri O; Martinelli N; Baroni M; Branchini A; Girelli D; Friso S; Pizzolo F; Bernardi F
J Am Heart Assoc; 2013 Nov; 2(6):e000440. PubMed ID: 24242684
[TBL] [Abstract][Full Text] [Related]
10. Plasma C20-Sphingolipids predict cardiovascular events independently from conventional cardiovascular risk factors in patients undergoing coronary angiography.
Othman A; Saely CH; Muendlein A; Vonbank A; Drexel H; von Eckardstein A; Hornemann T
Atherosclerosis; 2015 May; 240(1):216-21. PubMed ID: 25801014
[TBL] [Abstract][Full Text] [Related]
11. Long-Term Prognostic Utility of Coronary CT Angiography in Stable Patients With Diabetes Mellitus.
Blanke P; Naoum C; Ahmadi A; Cheruvu C; Soon J; Arepalli C; Gransar H; Achenbach S; Berman DS; Budoff MJ; Callister TQ; Al-Mallah MH; Cademartiri F; Chinnaiyan K; Rubinshtein R; Marquez H; DeLago A; Villines TC; Hadamitzky M; Hausleiter J; Shaw LJ; Kaufmann PA; Cury RC; Feuchtner G; Kim YJ; Maffei E; Raff G; Pontone G; Andreini D; Chang HJ; Chow BW; Min J; Leipsic J
JACC Cardiovasc Imaging; 2016 Nov; 9(11):1280-1288. PubMed ID: 27568114
[TBL] [Abstract][Full Text] [Related]
12. Levels of procoagulant factors and peak thrombin generation in relation to dementia risk in older adults: The Cardiovascular Health Study.
Harrington LB; Ehlert AN; Thacker EL; Jenny NS; Lopez O; Cushman M; Olson NC; Fitzpatrick A; Mukamal KJ; Jensen MK
Thromb Res; 2024 Mar; 235():148-154. PubMed ID: 38340522
[TBL] [Abstract][Full Text] [Related]
13. Activated and total coagulation factor VII, and fibrinogen in coronary artery disease.
Danielsen R; Onundarson PT; Thors H; Vidarsson B; Morrissey JH
Scand Cardiovasc J; 1998; 32(2):87-95. PubMed ID: 9636964
[TBL] [Abstract][Full Text] [Related]
14. Prognostic and therapeutic implications of statin and aspirin therapy in individuals with nonobstructive coronary artery disease: results from the CONFIRM (COronary CT Angiography EvaluatioN For Clinical Outcomes: An InteRnational Multicenter registry) registry.
Chow BJ; Small G; Yam Y; Chen L; McPherson R; Achenbach S; Al-Mallah M; Berman DS; Budoff MJ; Cademartiri F; Callister TQ; Chang HJ; Cheng VY; Chinnaiyan K; Cury R; Delago A; Dunning A; Feuchtner G; Hadamitzky M; Hausleiter J; Karlsberg RP; Kaufmann PA; Kim YJ; Leipsic J; LaBounty T; Lin F; Maffei E; Raff GL; Shaw LJ; Villines TC; Min JK;
Arterioscler Thromb Vasc Biol; 2015 Apr; 35(4):981-9. PubMed ID: 25676000
[TBL] [Abstract][Full Text] [Related]
15. Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque.
Kowalski M
J Physiol Pharmacol; 2001 Aug; 52(1 Suppl 1):3-31. PubMed ID: 11795863
[TBL] [Abstract][Full Text] [Related]
16. Cystatin C is independently associated with total and cardiovascular mortality in individuals undergoing coronary angiography. The Ludwigshafen Risk and Cardiovascular Health (LURIC) study.
Woitas RP; Kleber ME; Meinitzer A; Grammer TB; Silbernagel G; Pilz S; Tomaschitz A; Weihrauch G; Dobnig H; März W; Scharnagl H
Atherosclerosis; 2013 Aug; 229(2):541-8. PubMed ID: 23706287
[TBL] [Abstract][Full Text] [Related]
17. An elevated ratio of placental growth factor to soluble fms-like tyrosine kinase-1 predicts adverse outcomes in patients with stable coronary artery disease.
Matsumoto T; Uemura S; Takeda Y; Matsui M; Okada S; Nishida T; Soeda T; Okayama S; Somekawa S; Ishigami K; Onoue K; Kawata H; Kawakami R; Horii M; Saito Y
Intern Med; 2013; 52(10):1019-27. PubMed ID: 23676585
[TBL] [Abstract][Full Text] [Related]
18. Plasma big endothelin-1 levels at admission and future cardiovascular outcomes: A cohort study in patients with stable coronary artery disease.
Zhou BY; Guo YL; Wu NQ; Zhu CG; Gao Y; Qing P; Li XL; Wang Y; Dong Q; Liu G; Xu RX; Cui CJ; Sun J; Li JJ
Int J Cardiol; 2017 Mar; 230():76-79. PubMed ID: 28038820
[TBL] [Abstract][Full Text] [Related]
19. Plasma adiponectin levels in relation to prognosis in patients with angiographic coronary artery disease.
Li Q; Lu Y; Sun L; Yan J; Yan X; Fang L; Li M; Fan Z
Metabolism; 2012 Dec; 61(12):1803-8. PubMed ID: 22789446
[TBL] [Abstract][Full Text] [Related]
20. Galectin-3 binding protein, coronary artery disease and cardiovascular mortality: Insights from the LURIC study.
Gleissner CA; Erbel C; Linden F; Domschke G; Akhavanpoor M; Helmes CM; Doesch AO; Kleber ME; Katus HA; Maerz W
Atherosclerosis; 2017 May; 260():121-129. PubMed ID: 28390290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
